International Journal of Diabetes Mellitus
Volume 2, Issue 2 , Pages 114-118 , August 2010

T-cell protein tyrosine phosphatase: A role in inflammation and autoimmunity

  • Dimitry A. Chistiakov

      Affiliations

    • Department of Molecular Diagnostics, National Research Center GosNIIgenetika, 113545 Moscow, Russia
    • Corresponding Author InformationCorresponding author. Address: Department of Molecular Diagnostics, National Research Center GosNIIgenetika, 1st Dorozhny Proezd 1, 117545 Moscow, Russia. Tel.: +7 (495) 3150265; fax: +7 (495) 3150501.
    • ,
  • Emma I. Chistiakova

      Affiliations

    • Department of Diabetology, Endocrinological Research Center, 117036 Moscow, Russia

Received 7 February 2010 ,Revised 23 May 2010 ,Accepted 24 May 2010.

References 

  1. Alonso A, Sasin J, Bottini N, Friedberg I, Friedberg I, Osterman A, et al. Protein tyrosine phosphatases in the human genome. Cell. 2004;117:699–711
  2. Mustelin T, Vang T, Bottini N. Protein tyrosine phosphatases and the immune response. Nat Rev Immunol. 2005;5:43–57
  3. Hendriks WJAJ, Elson A, Harroch S, Stoker AW. Protein tyrosine phosphatases: functional inferences from mouse models and human diseases. FEBS J. 2008;275:816–830
  4. You-Ten KE, Muise ES, Itie A, Wolfkamp SC, Henckaerts L, Schreiber S, et al. Impaired bone marrow microenvironment and immune function in T cell protein tyrosine phosphatase-deficient mice. J Exp Med. 1997;186:683–693
  5. Dupuis M, De Jesus Ibarra-Sanchez M, Tremblay ML, Duplay P. Gr-1+ myeloid cells lacking T cell protein tyrosine phosphatase inhibit lymphocyte proliferation by an IFN-gamma- and nitric oxide-dependent mechanism. J Immunol. 2003;171:726–732
  6. Heinonen KM, Nestal FP, Newell EW, Charette G, Seemayer TA, Tremblay ML, et al. T-cell protein tyrosine phosphatase deletion results in progressive systemic inflammatory disease. Blood. 2004;103:3457–3464
  7. Vang T, Miletic AV, Arimura Y, Tautz L, Rickert RC, Mustelin T. Protein tyrosine phosphatases in autoimmunity. Annu Rev Immunol. 2008;26:29–55
  8. Johnson CV, Cool DE, Glaccum M, Green N, Fischer EH, Bruskin A, et al. Isolation and mapping of human T-cell protein tyrosine phosphatase sequences: localization of genes and pseudogenes discriminated using fluorescence hybridization with genomic versus cDNA probes. Genomics. 1993;16:619–629
  9. Cool DE, Tonks NK, Charbonneau H, Walsh KA, Fischer EH, Krebs EG. cDNA isolated from a human T-cell library encodes a member of the protein-tyrosine-phosphatase family. Proc Natl Acad Sci USA. 1989;86:5257–5261
  10. Wee C, Muise ES, Coquelet O, Ennis M, Wagner J, Lemieux N, et al. Promoter analysis of murine T-cell protein tyrosine phosphatase gene. Gene. 1999;237:351–360
  11. Ibarra-Sanchez MJ, Wagner J, Ong MT, Lampron C, Tremblay ML. Murine embryonic fibroblasts lacking TC-PTP display delayed G1 phase trough detective NF-kappaB activation. Oncogene. 2001;20:4728–4739
  12. Rajendrakumar GV, Radha V, Swamp G. Stabilization of a protein-tyrosine phosphatase mRNA upon mitogenic stimulation of T lymphocytes. Biochim Biophys Acta. 1993;1216:205–212
  13. Williams L, Bradley L, Smith A, Foxwell B. Signal transducer and activator of transcription 3 is the dominant mediator of anti-inflammatory effects of IL-10 in human macrophages. J Immunol. 2004;172:567–576
  14. Lorenzen JA, Dadabay CY, Fischer EH. COOH-terminal sequence motifs target the T cell protein tyrosine phosphatase to the ER and nucleus. J Cell Biol. 1995;131:631–643
  15. Kamatkar S, Radha V, Nambirajan S, Reddy RS, Swarup G. Two splice variants of a tyrosine phosphatase differ in substrate specificity, DNA binding and subcellular location. J Biol Chem. 1996;271:26755–26761
  16. Tonks NK, Diltz CD, Fischer EH. Purification of the major protein-tyrosine-phosphatases of human placenta. J Biol Chem. 1988;263:6722–6730
  17. Iversen LF, Moller KB, Pedersen AK, Peters GH, Petersen AS, Andersen HS, et al. Structure determination of T cell protein tyrosine phosphatase. J Biol Chem. 2002;277:19982–19990
  18. Gupta V, Swarup G. Evidence for a role of transmembrane protein p25 in localization of protein tyrosine phosphatase TC48 to the ER. J Cell Sci. 2006;119:1703–1714
  19. Zander NF, Cool DE, Diltz CD, Rohrschneider LR, Krebs EG, Fischer EH, et al. Suppression of v-fms-induced transformation by overexpression of a truncated T-cell protein tyrosine phosphatase. Oncogene. 1993;8:1175–1182
  20. Hao LN, Tiganis T, Tonks NK, Charbonneau H. The noncatalytic C-terminal segment of the T cell protein tyrosine phosphatase regulates activity via an intramolecular mechanism. J Biol Chem. 1997;272:22–29
  21. Bourdeau A, Dube N, Tremblay ML. Cytoplasmic protein tyrosine phosphatases, regulation and function: the roles of PTP1B and TC-PTP. Curr Opin Cell Biol. 2005;17:203–209
  22. Tillmann U, Wagner J, Boerboom D, Westphal H, Tremblay ML. Nuclear localization and cell cycle regulation of a murine protein tyrosine phosphatase. Mol Cell Biol. 1994;14:3030–3040
  23. Tiganis T, Bennett AM, Ravichandran KS, Tonks NK. Epidermal growth factor receptor and the adaptor protein p52Shc are specific substrates of T-cell protein tyrosine phosphatase. Mol Cell Biol. 1998;18:1622–1634
  24. Fauman FB, Saper MA. Structure and function of the protein tyrosine phosphatases. Trends Biochem Sci. 1996;21:413–417
  25. Meng TC, Buckley DA, Galic S, Tiganis T, Tonks NK. Regulation of insulin signaling through reversible oxidation of the protein-tyrosine phosphatases TC45 and PTP1B. J Biol Chem. 2004;279:37716–37725
  26. Galic S, Hauser C, Kahn BB, Haj FG, Neel BG, Tonks NK, et al. Coordinated regulation of insulin signaling by the protein tyrosine phosphatases PTP1B and TCPTP. Mol Cell Biol. 2005;25:819–829
  27. Bukczynska P, Klingler-Hoffmann M, Mitchelhill KI, Haj FG, Neel BG, Tonks NK, et al. The T-cell protein tyrosine phosphatase is phosphorylated on Ser-304 by cyclin-dependent protein kinases in mitosis. Biochem J. 2004;380:939–949
  28. Galic S, Klingler-Hoffmann M, Fodero-Tavoletti MT, Puryer MA, Meng TC, Tonks NK, et al. Regulation of insulin receptor signaling by the protein tyrosine phosphatase TCPTP. Mol Cell Biol. 2003;23:2096–2108
  29. Tiganis T, Flint AJ, Adam SA, Tonks NK. Association of the T-cell tyrosine phosphatase with nuclear import factor p97. J Biol Chem. 1998;272:21548–21557
  30. Persson C, Savenhed C, Bourdeau A, Tremblay ML, Markova B, Böhmer FD, et al. Site-selective regulation of platelet-derived growth factor beta receptor tyrosine phosphorylation by T-cell protein tyrosine phosphatase. Mol Cell Biol. 2004;24:2190–2201
  31. Simoncic PD, Bordeau A, Lee-Loy A, Rohrschneider LR, Tremblay ML, Stanley ER, et al. T-cell protein tyrosine phosphatase (Tcptp) is a negative regulator of colony-stimulating factor 1 signaling and macrophage differentiation. Mol Cell Biol. 2006;26:4149–4160
  32. Stanley ER, Berg KL, Einstein DB, Lee PS, Pixley FJ, Wang Y, et al. Biology and action of colony-stimulating factor-1. Mol Reprod Dev. 1997;46:4–10
  33. Gobert Gosse S, Bourgin C, Liu WQ, Garbay C, Mouchiroud G. M-CSF stimulated differentiation requires persistent MEK activity and MAPK phosphorylation independent of Grb2-Sos association and phosphatidylinositol 3-kinase activity. Cell Signal. 2005;17:1352–1362
  34. Csar XF, Wilson NJ, McMahon KA, Marks DC, Beecroft TL, Ward AC, et al. Proteomic analysis of macrophage differentiation p46/52(Shc) tyrosine phosphorylation is required for CSF-1-mediated macrophage differentiation. J Biol Chem. 2001;276:26211–26217
  35. Kharbanda S, Saleem A, Yuan Z, Emoto Y, Prasad KV, Kufe D. Stimulation of human monocytes with macrophage colony-stimulating factor induces a Grb2-mediated association of the focal adhesion kinase pp125FAK and dynamin. Proc Natl Acad Sci USA. 1995;92:6132–6136
  36. Van Vliet C, Bukczynska PE, Puryer MA, Sadek CM, Shields BJ, Tremblay ML, et al. Selective regulation of tumor necrosis factor-induced Erk signaling by Src family kinases and the T cell protein tyrosine phosphatase gene. Nat Immunol. 2005;6:253–260
  37. Simoncic PD, Lee-Loy A, Barber DL, Tremblay ML, McGlade CJ. The T cell protein phosphatase is a negative regulator of Janus family kinases 1 and 3. Curr Biol. 2002;12:446–453
  38. ten Hoeve J, de Jesus Ibarra-Sanchez M, Fu Y, Zhu W, Tremblay M, David M, et al. Identification of a nuclear Stat1 protein tyrosine phosphatase. Mol Cell Biol. 2002;22:5662–5668
  39. Zhu W, Mustelin T, David M. Arginine methylation of STAT1 regulates its dephosphorylation by T cell protein tyrosine phosphatase. J Biol Chem. 2002;277:35787–35790
  40. Aoki N, Matsuda T. A nuclear protein-tyrosine phosphatase TC-PTP is a potential negative regulator of the PRL-mediated signaling pathway: dephosphorylation and deactivation of signal transducer and activator of transcription 5a and 5b by TC-PTP in nucleus. Mol Endocrinol. 2002;16:58–69
  41. Yamamoto T, Sekine Y, Kashima K, Kubota A, Sato N, Aoki N, et al. The nuclear isoform of protein-tyrosine phosphatase TC-PTP regulates interleukin-6-mediated signaling pathway through STAT3 dephosphorylation. Biochem Biophys Res Commun. 2002;297:811–817
  42. Todd JA, Walker NM, Cooper JD, Smyth DJ, Downes K, Plagnol V, et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet. 2007;39:857–864
  43. Wellcome Trust Case Control Consortium . Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007;447:661–678
  44. The International HapMap Consortium . A haplotype map of the human genome. Nature. 2005;437:1299–1320
  45. Cooper JD, Smyth DJ, Smiles AM, Plagnol V, Walker NM, Allen JE, et al. Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci. Nat Genet. 2008;40:1399–1401
  46. Parkes M, Barrett JC, Prescott NJ, Tremelling M, Anderson CA, Fisher SA, et al. Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn’s disease susceptibility. Nat Genet. 2007;39:830–832
  47. Franke A, Balschun T, Karlsen , Hedderich J, May S, Lu T, et al. Replication of signals from recent studies of Crohn’s disease identifies previously unknown disease loci for ulcerative colitis. Nat Genet. 2008;40:713–715
  48. Smyth DJ, Plagnol V, Walker NM, Cooper JD, Downes K, Yang JH, et al. Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med. 2008;359:2767–2777
  49. Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, Rioux JD, et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn’s disease. Nat Genet. 2008;40:955–962
  50. Weersma PK, Stokkers PC, Cleynen I, Wolfkamp SC, Henckaerts L, Schreiber S, et al. Confirmation of multiple Crohn’s disease susceptibility loci in a large Dutch–Belgian cohort. Am J Gastroenterol. 2009;104:630–638
  51. Cronstein BN. Interleukin-6 – a key mediator of systemic and local symptoms in rheumatoid arthritis. Bull NYU Hosp Jt Dis. 2007;65(Suppl. 1):S11–S15
  52. Vang T, Miletic AV, Bottini N, Mustelin T. Protein tyrosine phosphatase PTPN22 in human autoimmunity. Autoimmunity. 2007;40:453–461

PII: S1877-5934(10)00034-2

doi: 10.1016/j.ijdm.2010.05.012

International Journal of Diabetes Mellitus
Volume 2, Issue 2 , Pages 114-118 , August 2010

Article Tools

* Image Usage & Resolution